3/18
11:28 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
3/18
11:28 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
3/18
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
3/18
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $67.00 price target on the stock.
3/18
06:22 am
mltx
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
Medium
Report
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
3/18
06:22 am
mltx
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
Medium
Report
MoonLake Immunotherapeutics initiated with an Outperform at RBC Capital
2/27
11:58 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
2/27
11:58 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
2/27
11:58 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
2/27
08:08 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Low
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
2/27
04:46 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
2/27
04:46 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
1/17
04:29 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
1/17
04:29 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
1/17
04:29 am
mltx
Rating for MLTX
Low
Report
Rating for MLTX
1/16
04:05 pm
mltx
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
1/16
04:05 pm
mltx
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
1/16
04:05 pm
mltx
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
Low
Report
MoonLake Immunotherapeutics upgraded to Buy from Neutral at Goldman Sachs
1/10
08:03 am
mltx
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.
Medium
Report
MoonLake Immunotherapeutics (NASDAQ: MLTX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $100.00 price target on the stock.